8W1U
 
 | | SARS-CoV-2 Main protease bound to non-covalent lead molecule NZ-804 | | Descriptor: | 11-[1-(1H-pyrrolo[3,2-c]pyridine-7-carbonyl)piperidin-4-ylidene]-6,11-dihydro-5H-5lambda~6~-dibenzo[b,e]thiepine-5,5-dione, 3C-like proteinase nsp5, DIMETHYL SULFOXIDE | | Authors: | Bian, X, Tang, S, Sacchettini, J.C. | | Deposit date: | 2024-02-18 | | Release date: | 2024-11-20 | | Method: | X-RAY DIFFRACTION (2.05 Å) | | Cite: | An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo.
Cell Rep, 43, 2024
|
|
8W1T
 | | SARS-CoV-2 Main protease bound to a non-covalent non-peptidic HTS hit | | Descriptor: | (5-bromopyridin-3-yl){4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}methanone, (5-bromopyridin-3-yl){4-[(S)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}methanone, 1,2-ETHANEDIOL, ... | | Authors: | Bian, X, Tang, S, Sacchettini, J.C. | | Deposit date: | 2024-02-18 | | Release date: | 2024-11-20 | | Method: | X-RAY DIFFRACTION (1.76 Å) | | Cite: | An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo.
Cell Rep, 43, 2024
|
|
